Question 1

Who owns PPCB?

Accepted Answer

PROPANC BIOPHARMA INC (PPCB) is held by 5 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is UBS Group AG as of Q1 2026.

Question 2

Are institutions buying or selling PPCB?

Accepted Answer

In Q1 2026, 4 institutions opened or increased positions in PROPANC BIOPHARMA INC while 3 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on PPCB?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for PROPANC BIOPHARMA INC.

Question 4

How many hedge funds hold PPCB?

Accepted Answer

5 institutional investors report holding PROPANC BIOPHARMA INC (PPCB) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into PPCB?

Accepted Answer

As of Q1 2026, tracked institutions in PROPANC BIOPHARMA INC show 4 buyers versus 3 sellers — net inflows.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
UBS Group AG	New	182,614	$19,357	0.0%	+847.06%	28
JANE STREET GROUP, LLC	New	143,212	$15,180	0.0%	+847.06%	28
Marex Group Ltd	Increased	67,724(+4.2%)	$7,179	0.0%	-8.72%	11
XTX Topco Ltd	Decreased	12,098(-45.3%)	$1,282	0.0%	+177.59%	0
Virtu Financial LLC	New	40,748	$4	0.0%	+847.06%	15
TWO SIGMA INVESTMENTS, LP	Exited	0(-100.0%)	$8,724	0.0%	-70.69%	0
MORGAN STANLEY	Exited	0(-100.0%)	$1	0.0%	-90.71%	0

PROPANC BIOPHARMA INC

Continue exploring

Other Healthcare stocks held by institutions